25 results
424B5
IKT
Inhibikase Therapeutics Inc
1 Feb 24
Prospectus supplement for primary offering
4:49pm
contain provisions that could make it more difficult to acquire control of our company by means of a tender offer, open market purchases, a proxy contest … control of the company by means of a proxy contest, tender offer, merger or otherwise.
Advance Notice Procedure
Our By-Laws provide that stockholders
424B3
d60rh35hpj8 z8q
4 Apr 23
Prospectus supplement
4:57pm
POS AM
npnp0iwddbmzl6w65hex
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
424B5
mb758r03tb
16 May 22
Prospectus supplement for primary offering
9:47pm
PRE 14A
lc5t7d2 wmvxe
21 Apr 22
Preliminary proxy
4:33pm
S-3
7cu20puit m6
7 Feb 22
Shelf registration
12:00am
424B4
qij0qkoy kty
17 Jun 21
Prospectus supplement with pricing info
4:31pm
DRS
khn90c4m lcmrtxo3
2 Jun 21
Draft registration statement
12:00am
10-K
EX-4.19
tshgv8l
31 Mar 21
Annual report
2:14pm
424B4
cayw1dk9wdx647qd
28 Dec 20
Prospectus supplement with pricing info
6:04am